Skip to main content
Premium Trial:

Request an Annual Quote

RainDance Raises $37.5M, Plans to Expand into Medical Genetics Market

Premium

RainDance Technologies has raised $37.5 million in a Series D financing round, which it will use to expand into the medical genetics and research markets, as well as grow its global sales and support team. Additionally, it will develop and commercialize products for single-molecule digital PCR and single cell analysis.

The funding round was co-led by new investor Quaker BioVentures and existing investor Mohr Davidow Ventures. Alloy Ventures and Arcadia Woods also participated. As part of the round, Sherill Neff from Quaker BioVentures and Jeffrey Samberg from Acadia Woods will join RainDance's board of directors.

"This significant financing kicks off an extremely exciting year of product launches and commercial expansion for RainDance," president and CEO Roopom Banerjee said in a statement.

Bannerjee plans to discuss RainDance's new product portfolio at next week's Advances in Genome Biology and Technology meeting in Marco Island, Fla. Last June, he told In Sequence that the company was developing an ultra-deep resequencing application that will be particularly useful for analyzing rare mutations in gene panels from heterogeneous tumors by allowing users to analyze gene mutations present at a frequency of 1 percent or lower (IS 6/22/2010).

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.